Login

PT Solusi Tunas Pratama Tbk plans to increase its tower count from 1,000 in 2014 to 39,000. 00:10:00

Share On Facebook Share On Twitter

President Director/CEO/Secy, Solusi Tunas Pratama Tbk PT.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
City of Chandler Economic Development Director, Micah Miranda, engages in discussions with Dan Berenbaum, Chief Financial Officer of Everspin.
00:10:00
Global venture capital firm investing in technology and healthcare|Scott Sandell,General Partner,New Enterprise Associates
00:10:00
Growth and Acquisitions in the Commercial Real Estate Sector for 2024 | John Albright, CEO, CTO Realty Growth Inc.
00:10:00
Raising a 50M Fund to Elevate Diverse Founders|Joanna Lee Shevelenko,Founder and General Partner,f7 Ventures
00:10:00
Aurelia Metals: Strong Financial Performance and High-Grade Discoveries
00:10:00
The 3 Tax Traps Physicians Should Avoid: Expert Tips from Scott Sturgeon | Scott Sturgeon, Founder, Oread Wealth Partners.
00:10:00
Denison's Leadership and Role in Managing Uranium Participation Corporation
00:10:00
James Gorman, CEO of Morgan Stanley, emphasizes the importance of seizing opportunities for growth and leadership in the financial industry.
00:10:00
Zuckerberg's Challenges: Congressional Grilling and Impact on Facebook's Stock
00:10:00
Opportunistic Lending and Risk-Managed Investment in the U.S. Cannabis Industry|Andreas Bodmeier,CIO,Chicago Atlantic
00:10:00
Learn about the top trends and technologies in psychedelic therapeutics|Amy Kruse,General Partner,Prime Movers Lab
00:10:00
Unlocking Wealth: A Behavioral Approach with Kim Curtis

© 2026 Nehu